Stephens Inc’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$272K Buy
21,231
+1,895
+10% +$24.3K ﹤0.01% 1056
2025
Q1
$245K Buy
19,336
+6,947
+56% +$88.2K ﹤0.01% 1068
2024
Q4
$163K Sell
12,389
-318
-3% -$4.17K ﹤0.01% 1182
2024
Q3
$192K Buy
12,707
+896
+8% +$13.5K ﹤0.01% 1200
2024
Q2
$167K Sell
11,811
-348
-3% -$4.93K ﹤0.01% 1188
2024
Q1
$166K Sell
12,159
-677
-5% -$9.23K ﹤0.01% 1182
2023
Q4
$173K Buy
12,836
+1,288
+11% +$17.3K ﹤0.01% 1109
2023
Q3
$144K Sell
11,548
-95
-0.8% -$1.19K ﹤0.01% 1081
2023
Q2
$158K Buy
11,643
+236
+2% +$3.2K ﹤0.01% 1097
2023
Q1
$159K Sell
11,407
-2,518
-18% -$35.1K ﹤0.01% 1062
2022
Q4
$198K Sell
13,925
-77,220
-85% -$1.1M ﹤0.01% 1010
2022
Q3
$1.25M Buy
91,145
+48,168
+112% +$658K 0.03% 475
2022
Q2
$612K Buy
42,977
+32,549
+312% +$464K 0.01% 659
2022
Q1
$172K Sell
10,428
-55,139
-84% -$909K ﹤0.01% 1191
2021
Q4
$1.26M Sell
65,567
-52,416
-44% -$1.01M 0.02% 557
2021
Q3
$2.45M Buy
117,983
+1,898
+2% +$39.5K 0.04% 413
2021
Q2
$2.49M Buy
116,085
+99,524
+601% +$2.13M 0.04% 429
2021
Q1
$326K Buy
16,561
+913
+6% +$18K 0.01% 974
2020
Q4
$309K Buy
15,648
+626
+4% +$12.4K 0.01% 908
2020
Q3
$264K Buy
15,022
+2,084
+16% +$36.6K 0.01% 929
2020
Q2
$232K Buy
+12,938
New +$232K 0.01% 919
2019
Q1
Sell
-30,061
Closed -$454K 1192
2018
Q4
$454K Sell
30,061
-1,182
-4% -$17.9K 0.01% 728
2018
Q3
$638K Buy
31,243
+7,211
+30% +$147K 0.02% 711
2018
Q2
$452K Buy
24,032
+731
+3% +$13.7K 0.01% 625
2018
Q1
$448K Buy
23,301
+10,375
+80% +$199K 0.02% 517
2017
Q4
$254K Sell
12,926
-55,058
-81% -$1.08M 0.01% 600
2017
Q3
$1.46M Buy
+67,984
New +$1.46M 0.05% 316